ES Pharma SRL
ES Pharma reported total assets of 117,670 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Mar 2026).
The score of ES Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -17 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ES Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 16,341 € | ||||
| Equity | 90,644 € | ||||
| Cash | 100,099 € | ||||
| EBITDA | 21,302 € | ||||
| Total assets | 117,670 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 25 Mar 2026
- Year ended 30 Sep 2024filed on 01 Apr 2025
- Year ended 31 Aug 2023filed on 21 Feb 2024
- Year ended 31 Aug 2022filed on 31 Jan 2023
- Year ended 31 Aug 2021filed on 16 Feb 2022
ES Pharma's financial analysis
- Solvency77.0%sector median: 47.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ES Pharma
ES Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0711.982.968
- VAT number
- BE0711982968
- Peppol
- Registered · 0208:0711982968 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Oct 2018
- Registered office
- 7090 Braine-le-Comte
- Latest accounts
- 2025 · filed on 25 Mar 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
ES Pharma (SRL) has been based in Braine-le-Comte since 2018, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 16,341 € and equity of 90,644 €; its revenue is not published. Its solvency stands at 77.0%, above the median of its sector (47.1%).
Companies similar to ES Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Courouble Manufacture of basic pharmaceutical products Schaerbeek · balance sheet 129,672 €
- Care4Excellence Manufacture of pharmaceutical preparations Overijse · balance sheet 307,250 €
- Orthophar Manufacture of pharmaceutical preparations Kortrijk · balance sheet 258,756 €
- Coshomed Business and other management consultancy activities Lokeren · balance sheet 284,673 €
- Apomires Other business support service activities n.e.c. Tienen · balance sheet 101,247 €
- Bossiroy Pharma Retail sale of pharmaceutical products Uccle · balance sheet 65,695 €
- Felis Pharma Retail sale of pharmaceutical products Oosterzele · balance sheet 133,809 €
- Nzosshealth Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 201,994 €
Frequently asked questions about ES Pharma
What is the revenue of ES Pharma?
ES Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ES Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0711982968 for ES Pharma, if the company is VAT-registered. Its company number (CBE) is 0711.982.968.
Where is the registered office of ES Pharma?
According to the CBE register, the registered office of ES Pharma is in 7090 Braine-le-Comte.
What is the equity of ES Pharma?
At the close of the 2025 financial year, the equity of ES Pharma amounts to 90,644 €, a solvency of 77.0% of total assets.
Who manages ES Pharma?
The register lists 1 active mandates at ES Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ES Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →